Position in VTGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,265
-$3,010 QoQ
Shares Held
5,500
-26.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 48 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Performa Ltd (US), LLC holds $13,745 across 2 Biotechnology names. VTGN ranks #2 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,000 | $12,480 | |
| 2 | VTGN |
Vistagen Therapeutics, Inc.
This page
|
5,500 | $1,265 |
All Filings in VTGN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,265 | 5,500 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $4,275 | 7,500 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $660 | 1,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,550 | 1,000 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,000 | 1,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,500 | 1,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,950 | 1,000 | Shares | Sole | 2025-02-10 | |
| 2023-06-30 | $9,163 | 4,900 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $10,799 | 90,000 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $6,999 | 70,000 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $8,999 | 60,000 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $27,155 | 30,859 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $27,899 | 22,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $19,499 | 10,000 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $5,479 | 2,000 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,354 | 1,700 | Shares | Sole | 2021-07-28 | |
| No filing history on record for this holder in this stock. | ||||||